Study of 1.7 Million Kids and Teens Who Got Pfizer COVID Injections Found Myopericarditis Only in Vaxed Groups

From [HERE] The Pfizer-BioNTech COVID-19 vaccine provided children and teens in England with only about 14 to 15 weeks of protection against testing positive for the virus, according to a preprint study of over 1.7 million children ages 5 to 15 in the English National Healthcare System (NHS).

Researchers investigating the safety and effectiveness of Pfizer’s vaccine in fully vaccinated, partially vaccinated, and unvaccinated children and teens, also found cases of myocarditis and pericarditis only in vaccinated children.

“This study clearly shows that Pfizer’s COVID vaccine provides almost no benefit to children and adolescents, but does increase their risk of myocarditis and pericarditis,” said Brian Hooker, Ph.D., chief scientific officer of Children’s Health Defense. “It begs the question: Why does the CDC continue to recommend these unlicensed shots for kids? Where is the data they use to support their statement that the benefits of these vaccines outweigh the risks?”

The study found that vaccinated children required slightly fewer emergency room visits and hospital stays, but that those outcomes were extremely rare in children and teens across all groups.

There were no COVID-19 deaths among any of the study subjects.

Public health agencies in the United Kingdom (U.K.) and in the U.S. granted authorization to the Pfizer vaccines based on clinical trials that measured immunogenicity — or how well the vaccine elicited an immune response in the body — and efficacy against infection.

The trials didn’t test how well the vaccines protected against severe disease. They also didn’t assess particular safety endpoints, like myocarditis and pericarditis, which have been reported globally. [MORE]